Nada Hamad Selected Research

Nada Hamad Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 02/2015
13	COVID-19 04/2024 - 01/2020
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 07/2020
11	Lymphoma (Lymphomas) 04/2024 - 01/2021
8	Infections 03/2024 - 01/2021
8	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 11/2014
4	Bronchiolitis Obliterans Syndrome 11/2023 - 10/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 01/2022
3	Primary Myelofibrosis (Myelosclerosis) 12/2023 - 12/2020
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 01/2023
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 06/2014
2	Communicable Diseases (Infectious Diseases) 12/2023 - 01/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 11/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2023
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 11/2014
1	Lymphopenia (Lymphocytopenia) 03/2024
1	Splenomegaly 12/2023
1	Central Nervous System Diseases (CNS Diseases) 09/2023
1	Intraocular Lymphoma 09/2023
1	Acute Abdomen 02/2023
1	Acute Kidney Injury (Acute Renal Failure) 02/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2023
1	Premature Menopause 01/2023
1	Uterine Hemorrhage (Uterine Bleeding) 01/2023
1	Immunoglobulin Light-chain Amyloidosis 10/2022
1	Multiple Sclerosis 05/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Female Genital Diseases 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2021
1	Pathologic Complete Response 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2021
1	Poliomyelitis (Polio) 01/2021
1	Invasive Fungal Infections 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Smallpox (Variola) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Disease Progression 07/2020

Drug/Important Bio-Agent (IBA)

6	selinexorIBA 02/2022 - 07/2020
5	COVID-19 VaccinesIBA 01/2024 - 01/2021
5	VaccinesIBA 01/2024 - 01/2021
4	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2022
3	Rituximab (Mabthera)FDA Link 04/2024 - 11/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2023
3	SteroidsIBA 01/2024 - 01/2023
3	ibrutinibIBA 10/2023 - 01/2021
3	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 06/2014
2	Bendamustine Hydrochloride FDA Link 04/2024 - 03/2024
2	ruxolitinibIBA 11/2023 - 01/2023
2	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 10/2022
2	Calcineurin InhibitorsIBA 01/2023 - 01/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 11/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2021
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2015
1	polatuzumab vedotinIBA 04/2024
1	Dihydrotachysterol (AT 10)IBA 03/2024
1	obinutuzumabIBA 03/2024
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Janus Kinase InhibitorsIBA 12/2023
1	serum P-component (CIt)IBA 11/2023
1	margetuximabIBA 11/2023
1	fludarabineIBA 07/2023
1	Busulfan (Busulfex)FDA Link 07/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	defibrotideIBA 01/2023
1	Bortezomib (Velcade)FDA Link 10/2022
1	tisagenlecleucelIBA 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 11/2021
1	Prednisolone (Predate)FDA LinkGeneric 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 07/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Alemtuzumab (Campath)FDA Link 11/2014

Therapy/Procedure

29	Therapeutics 04/2024 - 06/2014
8	Stem Cell Transplantation 12/2023 - 05/2015
4	Transplantation 12/2023 - 01/2020
4	Hematopoietic Stem Cell Transplantation 12/2023 - 10/2020
4	Cell Transplantation 07/2023 - 11/2014
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2023
1	Photopheresis 01/2024
1	Critical Care (Surgical Intensive Care) 12/2023
1	Time-to-Treatment 12/2023
1	Donor Selection 12/2023
1	Contraception (Birth Control) 06/2023
1	Hysterectomy 02/2023
1	Art Therapy 01/2023
1	Homologous Transplantation 01/2023
1	Aftercare (After-Treatment) 12/2019